USA Rare Earth, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 10, 2026, covering the period ended June 30, 2026, and disclosing details on its operations, share count, and key pending transactions.
USA Rare Earth, Inc. filed a Current Report on Form 8-K on August 10, 2026, announcing the issuance of an earnings press release covering its financial results for the second quarter and six months ended June 30, 2026.
Director Jagroop Gill of Community West Bancshares filed a statement of changes in beneficial ownership with the SEC on August 10, 2026, reporting a purchase of common stock in the Fresno, California-based banking company.
WEBTOON Entertainment Inc. filed a Form 8-K on August 10, 2026, disclosing that it entered into a Share Purchase Agreement on August 6, 2026, to acquire up to 9,000 shares of RI Games Holdings Inc., a South Korea-based game developer, in two separate closings …
AST SpaceMobile, Inc. filed its quarterly report on Form 10-Q for the period ended June 30, 2026, disclosing total revenues of $31.5 million for the second quarter and a net loss attributable to common stockholders of $230.9 million, with total assets reaching $5.85 billion.
Community West Bancshares filed its quarterly report on Form 10-Q for the period ended June 30, 2026 with the Securities and Exchange Commission, reporting consolidated balance sheet figures and financial condition disclosures as of that date.
Director Brian P. Friedman filed a Form 4 with the SEC on August 10, 2026, disclosing a charitable gift of 59,619 shares of Vitesse Energy, Inc. (NYSE: VTS) common stock to a non-profit organization on August 7, 2026.
Devesh Agarwal, Chief Operating Officer of Bandwidth Inc. (NASDAQ: BAND), filed a Form 4 on August 10, 2026, disclosing the vesting of restricted stock units and a subsequent sale of Class A Common Stock on August 8 and August 10, 2026.
Michael George Rosenbaum, Chief Executive Officer and Director of Guidewire Software, Inc. (NYSE: GWRE), filed a Form 4 on August 10, 2026, disclosing the sale of 1,200 shares of common stock on that same date.
Jason Paul Steik, Chief Clinical Officer of Pennant Group, Inc. (NASDAQ: PNTG), filed a Form 4 on August 10, 2026, disclosing the sale of common stock on August 6, 2026, pursuant to a Rule 10b5-1 trading plan.